At 36 weeks, the TOGETHER-PsA study met its primary endpoint of 50% improvement in psoriatic arthritis (PsA) activity based on ACR50 in addition to 10% weight reduction with concomitant Taltz and Zep… [+26313 chars]
Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight - Eli Lilly
The Investor Relations website contains information about Eli Lilly and Company's business for stockholders, potential investors, and financial analysts.
Source:Lilly.com
Published:
Related News
Stocks recover from sell-off after Trump rules out military action on Greenland: Live updates - CNBC
All three major U.S. stock indexes logged their worst daily performances since Oct. 10 as Trump escalated his Greenland tariff threats.
CNBC•Sean Conlon, Chloe Taylor, Pia Singh
Volvo’s Electric EX60 SUV Has a 400-Mile Range—and Rethinks the Humble Seat Belt - WIRED
The Swedish brand’s latest computer-packed EV hopes to take on and beat the BMW iX3. But we’re more excited about the new seat belt.
Wired•Jeremy White
Supreme Court appears wary of allowing Trump to fire Fed's Cook in closely watched case - NPR
The administration wants the authority to fire Lisa Cook, a Fed governor. Experts say that would undermine the independence of the central bank.
NPR